COMMUNIQUÉS West-GlobeNewswire

Analogic to Demonstrate its Airport Checkpoint CT Scanner, ConneCT, in Four Global Regions by July 2018

22/02/2018 - 17:30

PEABODY, Mass., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq: ALOG ), enabling the world’s medical imaging and aviation security technology, today announced that the company intends to demonstrate the [...]

ELSALYS BIOTECH concludes with THEA a license option agreement on its ELB011 program in ophthalmology

22/02/2018 - 17:01

ELSALYS BIOTECH concludes with THEA a license option agreement on its ELB011 program in ophthalmology ELB011, a first-in-class antibody program, demonstrates an anti-angiogenic effect on the formation of new blood [...]

ELSALYS BIOTECH conclut avec THEA une option de licence sur son programme ELB011 en ophtalmologie

22/02/2018 - 17:01

ELSALYS BIOTECH conclut avec THEA une option de licence sur son programme ELB011 en ophtalmologie ELB011 est un programme d'anticorps first-in-class ayant démontré un effet anti-angiogénique sur la formation de néo- [...]

Tempus Launches Tempus xE, Whole Exome Sequencing to Empower Data-Driven Cancer Care and Research

22/02/2018 - 16:30

CHICAGO, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tempus, a technology company focused on helping doctors personalize cancer care by collecting and analyzing large volumes of molecular and clinical data, has launched a new [...]

Sienna Senior Living Inc. Announces Closing of Over-Allotment Option

22/02/2018 - 15:41

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MARKHAM, Ontario, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA ) [...]

Vistin Pharma ASA : Invitation to presentation of Q4 2017 results

22/02/2018 - 15:38

Oslo, 22 February 2018 Vistin Pharma ASA (OSE: VISTIN) will release its fourth quarter 2017 results on Tuesday 27 February 2018. The results will be presented by Vistin Pharma's CEO Kjell-Erik Nordby and CFO Gunnar [...]

Merit Medical to Participate at Six Conferences

22/02/2018 - 15:29

BTIG – March 1 Raymond James – March 7 Barclays – March 15 Oppenheimer – March 21 Needham – March 28 Sidoti – March 29 SOUTH JORDAN, Utah, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI ), a [...]

Midland, TX Hand Surgeon Launches Custom Specialty Website with Responsive Design

22/02/2018 - 15:01

MIDLAND, Texas, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Injuries and conditions of the hand and wrist often require the advanced skill of a plastic surgeon who has undergone extensive education in the delicate art of hand [...]

Mount Tam Biotechnologies Announces that the European Patent Office Has Allowed a Key Patent for Lead Compound TAM-01

22/02/2018 - 15:00

NOVATO, CA , Feb. 22, 2018 (GLOBE NEWSWIRE) -- Mount Tam Biotechnologies, Inc. ("Mount Tam") (OTC PINK: MNTM), a company focused on the discovery and development of novel mTOR inhibitors, is pleased to announce the [...]

Radient Technologies Inc. Named to the 2018 TSX Venture 50 List of Companies

22/02/2018 - 15:00

EDMONTON, Alberta, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX-V: RTI ), a world leader in industrial-scale natural ingredient extraction, purification and formulation [...]

Tower One to Spin Out USA-Based TCTS

22/02/2018 - 15:00

VANCOUVER, British Columbia, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (the “Company ” or “ Tower One ”) is pleased to announce that it intends to spin-out its [...]

Tetra Bio-Pharma Announces Filing of Restated Financial Statements and MD&A

22/02/2018 - 14:59

OTTAWA, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Corporation ”) (TSX-V: TBP ) (OTCQB:TBPMF), announced today it has filed restated Condensed Consolidated interim financial statements ( [...]

Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017

22/02/2018 - 14:45

LONDON, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

Apellis Pharmaceuticals Announces 18-Month Results of Phase 2 Study (FILLY) of APL-2 in Geographic Atrophy

22/02/2018 - 14:44

CRESTWOOD, Ky. and CAMBRIDGE, Mass., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS ), a clinical-stage biopharmaceutical company developing a platform of novel therapeutic compounds for [...]

Key Measure of Precipio’s Pathology Sales Growth 4X Prior Quarter

22/02/2018 - 14:39

NEW HAVEN, Conn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), announced today that within the first half of Q1-2018 it has set up trials for pathology lab services with 4 times as many new oncology [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

22/02/2018 - 14:01

FIT Biotech Oy Company release February 22, 2018 at 3:00 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Vericel to Report Fourth-Quarter and Full-Year 2017 Financial Results on March 5, 2018

22/02/2018 - 14:00

CAMBRIDGE, Mass., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast [...]

The Joint Corp. to Host Conference Call on Thursday, March 8, to Discuss Fourth Quarter and Full Year 2017 Results

22/02/2018 - 14:00

SCOTTSDALE, Ariz., Feb. 22, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT ), a national operator, manager and franchisor of chiropractic clinics, announced it will report its fourth quarter and full year 2017 [...]

ContraVir Pharmaceuticals Announces TXL™ Has Been Granted Orphan Drug Designation for the Treatment of HBV in a Pediatric Population

22/02/2018 - 14:00

EDISON, N.J., Feb. 22, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]